Stay updated on DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial
Sign up to get notified when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.

Latest updates to the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNon-significant site revision updates were made (Revision: v3.3.4 added; Revision: v3.3.3 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a Locations section listing Alberta, Nova Scotia, Ontario, and Quebec, and updated the page revision to v3.3.3. Removed the separate Alberta Locations, Nova Scotia Locations, Ontario Locations, and Quebec Locations blocks.SummaryDifference0.5%

- Check60 days agoChange DetectedAdded notes that publications are provided voluntarily and auto-filled from PubMed. Updated Revision to v3.3.2 and removed the earlier v3.2.0 wording.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoved the banner about government funding and NIH operating status; core study content and contact/locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedNo significant additions or deletions were detected; the page content remains largely unchanged aside from minor textual updates to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check110 days agoChange DetectedMajor update: new disease term added and software revision updated to v3.2.0, plus a prominent government operating-status notice. Overall, the page content and versioning have changed; no other critical items (pricing, availability) are affected.SummaryDifference2%

Stay in the know with updates to DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.